Last updated on January 2020

An Exploratory Maintenance Trial of BI 655064 in Patients With Lupus Nephritis

Brief description of study

The main objectives of this trial are to evaluate the long term efficacy and safety of different doses of BI 655064 versus placebo as add-on therapy to Standard of Care (SOC) during maintenance therapy for lupus nephritis.

Clinical Study Identifier: NCT03385564

Find a site near you

Start Over

Guy's Hospital

London, United Kingdom
  Connect »

Northwell Health

Great Neck, NY United States
  Connect »

Queen Mary Hospital

Hong Kong, Hong Kong
  Connect »

Addenbrooke's Hospital

Cambridge, United Kingdom
  Connect »

Ajou University Hospital

Suwon, Korea, Republic of
  Connect »

Mary Mediatrix Medical Center

Lipa City, Batangas, Philippines
  Connect »